pharmaphorum November 11, 2024
Phil Taylor

Researchers in the US have developed an artificial intelligence algorithm that can sift through electronic health records (EHRs) and help physicians to detect undiagnosed cases of long COVID.

Along with identifying people who should be receiving care for the potentially debilitating condition, the algorithm could also be used to try to find the genetic and biochemical factors behind the still-mysterious condition, which causes a range of symptoms including extreme tiredness, shortness of breath, chest pain, problems with memory, difficulty sleeping, heart palpitations, and dizziness.

According to the US Centers for Disease Control and Prevention (CDC), approximately 7.5% of the adult population of the US have symptoms of long COVID, which works out at 24.75 million individuals.

The new algorithm –...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), EMR / EHR, Healthcare System, Patient / Consumer, Provider, Public Health / COVID, Technology
Navigating the world of artificial intelligence in health care
Cohere just launched ‘North,’ its biggest AI bet yet for privacy-focused enterprises
AI's Role in Oncology: Supporting, Not Replacing, Health Care Providers
Unlocking peak operational performance in clinical development with artificial intelligence
Boosting biopharma R&D performance with a next-generation technology stack

Share This Article